Literature DB >> 33568184

Changes in opioid-related deaths following increased access to opioid substitution treatment.

Lisa Andersson1, Anders Håkansson2, Jonas Berge2,3, Björn Johnson4.   

Abstract

BACKGROUND: Opioid-related mortality is high and increasing in the Western world, and interventions aimed at reducing opioid-related deaths represent an important area of study. In Skåne County, Sweden, a patient choice reform resulted in increased access to opioid substitution treatment (OST). In addition, a gradual shift towards less restrictive terms for exclusion from OST has been implemented. The aim of this study was to assess the impact of these policy changes on opioid-related deaths.
METHODS: Detailed data on opioid-related deaths in Skåne during the 2 years prior to and following the policy change were obtained from forensic records and from health care services. Data on overdose deaths for Skåne and the rest of Sweden were obtained using publicly available national register data. Time periods were used as the predictor for opioid-related deaths in the forensic data. The national level data were used in a natural experiment design in which rates of overdose deaths were compared between Skåne and the rest of Sweden before and after the intervention.
RESULTS: There was no significant difference in the number of deaths in Skåne between the data collection periods (RR: 1.18 95% CI:0.89-1.57, p= 0.251). The proportion of deaths among patients enrolled in OST increased between the two periods (2.61, 1.12-6.10, p= 0.026). There was no change in deaths related to methadone or buprenorphine in relation to deaths due to the other opioids included in the study (0.92, 0.51-1.63, p= 0.764). An analysis of national mortality data showed an annual relative decrease in unintentional drug deaths in Skåne compared to the rest of Sweden following the onset of the reform (0.90, 0.84-0,97, p= 0.004).
CONCLUSIONS: Opioid-related deaths, as assessed using forensic data, has not changed significantly in Skåne following a change to lower-threshold OST. By contrast, national level data indicate that the policy change has been associated with decreased overdose deaths. The discrepancy between these results highlights the need for more research to elucidate this issue. The result that more patients die during ongoing OST following an increase in access to treatment underlines the need for further preventive interventions within the OST treatment setting.

Entities:  

Keywords:  Low threshold; Mortality; Opioid; Opioid substitution treatment; Opioid-related deaths; Sweden; Treatment access

Year:  2021        PMID: 33568184      PMCID: PMC7876792          DOI: 10.1186/s13011-021-00351-4

Source DB:  PubMed          Journal:  Subst Abuse Treat Prev Policy        ISSN: 1747-597X


  37 in total

1.  [More and more methadone deaths. "Leakage" from ongoing more liberal treatment programs might be a cause].

Authors:  Anna Fugelstad; Age Johansson Lars; Ingemar Thiblin
Journal:  Lakartidningen       Date:  2010 May 5-11

2.  Changes in illicit opioid use across Canada.

Authors:  Benedikt Fischer; Jürgen Rehm; Jayadeep Patra; Michelle Firestone Cruz
Journal:  CMAJ       Date:  2006-11-21       Impact factor: 8.262

Review 3.  The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction.

Authors:  Andrew Kolodny; David T Courtwright; Catherine S Hwang; Peter Kreiner; John L Eadie; Thomas W Clark; G Caleb Alexander
Journal:  Annu Rev Public Health       Date:  2015-01-12       Impact factor: 21.981

4.  Methadone-Related Overdose Deaths in a Liberal Opioid Maintenance Treatment Programme.

Authors:  Christian Tjagvad; Svetlana Skurtveit; Kristian Linnet; Ljubica Vukelic Andersen; Dorte J Christoffersen; Thomas Clausen
Journal:  Eur Addict Res       Date:  2016-06-01       Impact factor: 3.015

5.  A Public Health Strategy for the Opioid Crisis.

Authors:  Brendan Saloner; Emma E McGinty; Leo Beletsky; Ricky Bluthenthal; Chris Beyrer; Michael Botticelli; Susan G Sherman
Journal:  Public Health Rep       Date:  2018 Nov/Dec       Impact factor: 2.792

6.  Mortality related to methadone maintenance treatment in Stockholm, Sweden, during 2006-2013.

Authors:  Anders Ledberg
Journal:  J Subst Abuse Treat       Date:  2016-12-24

7.  Comparison of ethyl glucuronide in hair with phosphatidylethanol in whole blood as post-mortem markers of alcohol abuse.

Authors:  Peter Bendroth; Robert Kronstrand; Anders Helander; Jesper Greby; Nikolai Stephanson; Peter Krantz
Journal:  Forensic Sci Int       Date:  2007-11-19       Impact factor: 2.395

Review 8.  Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence.

Authors:  Richard P Mattick; Courtney Breen; Jo Kimber; Marina Davoli
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08

9.  The burden of premature opioid-related mortality.

Authors:  Tara Gomes; Muhammad M Mamdani; Irfan A Dhalla; Stephen Cornish; J Michael Paterson; David N Juurlink
Journal:  Addiction       Date:  2014-07-07       Impact factor: 6.526

10.  The Swedish cause of death register.

Authors:  Hannah Louise Brooke; Mats Talbäck; Jesper Hörnblad; Lars Age Johansson; Jonas Filip Ludvigsson; Henrik Druid; Maria Feychting; Rickard Ljung
Journal:  Eur J Epidemiol       Date:  2017-10-05       Impact factor: 8.082

View more
  2 in total

1.  Dealing with low access to harm reduction: a qualitative study of the strategies and risk environments of people who use drugs in a small Swedish city.

Authors:  Julie Holeksa
Journal:  Harm Reduct J       Date:  2022-03-04

2.  M2HepPrEP: study protocol for a multi-site multi-setting randomized controlled trial of integrated HIV prevention and HCV care for PWID.

Authors:  Valérie Martel-Laferrière; Daniel J Feaster; Lisa R Metsch; Bruce R Shackman; Christine Loignon; Bohdan Nosyk; Hansel Tookes; Czarina N Behrends; Nelson Arruda; Oluleye Adigun; Marie-Eve Goyer; Michael A Kolber; Jean-Francois Mary; Allan E Rodriguez; Iveth G Yanez; Yue Pan; Rania Khemiri; Lauren Gooden; Aïssata Sako; Julie Bruneau
Journal:  Trials       Date:  2022-04-23       Impact factor: 2.728

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.